Enfuvirtide (T-20) Peptide

Enfuvirtide is an envelope fusion inhibitor used to treat HIV-infected patients. The peptide binds to the HIV envelope glycoprotein gp41 and prevents viral fusion with the target cell membrane. Enfuvirtide (Fuzeon/Roche) was approved by the FDA in 2003.